Evaluation of Ocular Surface Parameters and Systemic Inflammatory Biomarkers in Hazelnut Harvesters
CONCLUSION: In hazelnut harvesters, ocular allergy and inflammation may be associated with systemic biomarkers.PMID:38557359 | DOI:10.1080/09273948.2024.2336598 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - April 1, 2024 Category: Allergy & Immunology Authors: Sevde Akcay Usta Mehmet Icoz Source Type: research
Multiple Sclerosis-Associated Uveitis: A Case Report of Refractory Bilateral Chronic Granulomatous Panuveitis Successfully Treated with Tocilizumab
CONCLUSIONS: Tocilizumab appears to be an efficient option for managing uveitis associated with MS and may be a valuable choice for clinicians dealing with such cases.PMID:38546424 | DOI:10.1080/09273948.2024.2332783 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - March 28, 2024 Category: Allergy & Immunology Authors: William Gil Hassan Lagrib Louis Olagne C éline Tilignac Maud Perie Fr édéric Taithe Xavier Moisset Frederic Chiambaretta Pierre Clavelou Marc Andre Ludovic Trefond Source Type: research
Uveitic Macular Edema: Clinical Outcomes in Real-World Practice
CONCLUSIONS: Management of CME is challenging given the heterogeneous aetiologies, severity of the macular edema as well as response to the therapy. A high rate of resolution was observed, given sufficient time, but recurrence occurs in one-third. Current smoking status plays an important role in the risk of recurrence of CME and patients should be encouraged to stop smoking.PMID:38547157 | DOI:10.1080/09273948.2024.2328769 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - March 28, 2024 Category: Allergy & Immunology Authors: Nazima Ali Joanne Sims Rachael Niederer Source Type: research
Multiple Sclerosis-Associated Uveitis: A Case Report of Refractory Bilateral Chronic Granulomatous Panuveitis Successfully Treated with Tocilizumab
CONCLUSIONS: Tocilizumab appears to be an efficient option for managing uveitis associated with MS and may be a valuable choice for clinicians dealing with such cases.PMID:38546424 | DOI:10.1080/09273948.2024.2332783 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - March 28, 2024 Category: Allergy & Immunology Authors: William Gil Hassan Lagrib Louis Olagne C éline Tilignac Maud Perie Fr édéric Taithe Xavier Moisset Frederic Chiambaretta Pierre Clavelou Marc Andre Ludovic Trefond Source Type: research
Uveitic Macular Edema: Clinical Outcomes in Real-World Practice
CONCLUSIONS: Management of CME is challenging given the heterogeneous aetiologies, severity of the macular edema as well as response to the therapy. A high rate of resolution was observed, given sufficient time, but recurrence occurs in one-third. Current smoking status plays an important role in the risk of recurrence of CME and patients should be encouraged to stop smoking.PMID:38547157 | DOI:10.1080/09273948.2024.2328769 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - March 28, 2024 Category: Allergy & Immunology Authors: Nazima Ali Joanne Sims Rachael Niederer Source Type: research
Multiple Sclerosis-Associated Uveitis: A Case Report of Refractory Bilateral Chronic Granulomatous Panuveitis Successfully Treated with Tocilizumab
CONCLUSIONS: Tocilizumab appears to be an efficient option for managing uveitis associated with MS and may be a valuable choice for clinicians dealing with such cases.PMID:38546424 | DOI:10.1080/09273948.2024.2332783 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - March 28, 2024 Category: Allergy & Immunology Authors: William Gil Hassan Lagrib Louis Olagne C éline Tilignac Maud Perie Fr édéric Taithe Xavier Moisset Frederic Chiambaretta Pierre Clavelou Marc Andre Ludovic Trefond Source Type: research
Uveitic Macular Edema: Clinical Outcomes in Real-World Practice
CONCLUSIONS: Management of CME is challenging given the heterogeneous aetiologies, severity of the macular edema as well as response to the therapy. A high rate of resolution was observed, given sufficient time, but recurrence occurs in one-third. Current smoking status plays an important role in the risk of recurrence of CME and patients should be encouraged to stop smoking.PMID:38547157 | DOI:10.1080/09273948.2024.2328769 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - March 28, 2024 Category: Allergy & Immunology Authors: Nazima Ali Joanne Sims Rachael Niederer Source Type: research
Multiple Sclerosis-Associated Uveitis: A Case Report of Refractory Bilateral Chronic Granulomatous Panuveitis Successfully Treated with Tocilizumab
CONCLUSIONS: Tocilizumab appears to be an efficient option for managing uveitis associated with MS and may be a valuable choice for clinicians dealing with such cases.PMID:38546424 | DOI:10.1080/09273948.2024.2332783 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - March 28, 2024 Category: Allergy & Immunology Authors: William Gil Hassan Lagrib Louis Olagne C éline Tilignac Maud Perie Fr édéric Taithe Xavier Moisset Frederic Chiambaretta Pierre Clavelou Marc Andre Ludovic Trefond Source Type: research
Bilateral Retinal Venous Occlusion in Atypical Hemolytic-Uremic Syndrome Due to Complement Factor H Mutation
CONCLUSION: Diagnosis of aHUS is challenging especially during pregnancy and the postpartum period. Although ocular involvement is quite rare, we described bilateral RVO in aHUS case with homozygous nonsense mutation (c.2134 G > T p.G712). Dexamethasone implant should be considered for the treatment of RVO in aHUS cases.PMID:38536978 | DOI:10.1080/09273948.2024.2333401 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - March 27, 2024 Category: Allergy & Immunology Authors: Saban Gonul Serhat Eker Source Type: research
Demographic and Clinical Profile of Pediatric Uveitis in Delta Region, Egypt
CONCLUSION: Anterior uveitis was the most frequent presentation in our pediatric cohort. Despite the challenges, the majority of children with uveitis exhibited no significant visual impairment, with most causes of visual loss being reversible.PMID:38527189 | DOI:10.1080/09273948.2024.2328789 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - March 25, 2024 Category: Allergy & Immunology Authors: Nagwa Hussein Abdelmageed Anas Adi Samy Abo El-Khair Maha Shahin Doaa Mosad Mosa Dalia Sabry Amgad El Nokrashy Source Type: research
Monkeypox
Ocul Immunol Inflamm. 2024 Apr;32(3):251-252. doi: 10.1080/09273948.2023.2298177. Epub 2024 Mar 25.NO ABSTRACTPMID:38527231 | DOI:10.1080/09273948.2023.2298177 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - March 25, 2024 Category: Allergy & Immunology Authors: Derrick P Smit Ilknur Tugal-Tutkun Jennifer E Thorne Source Type: research
Demographic and Clinical Profile of Pediatric Uveitis in Delta Region, Egypt
CONCLUSION: Anterior uveitis was the most frequent presentation in our pediatric cohort. Despite the challenges, the majority of children with uveitis exhibited no significant visual impairment, with most causes of visual loss being reversible.PMID:38527189 | DOI:10.1080/09273948.2024.2328789 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - March 25, 2024 Category: Allergy & Immunology Authors: Nagwa Hussein Abdelmageed Anas Adi Samy Abo El-Khair Maha Shahin Doaa Mosad Mosa Dalia Sabry Amgad El Nokrashy Source Type: research
Monkeypox
Ocul Immunol Inflamm. 2024 Apr;32(3):251-252. doi: 10.1080/09273948.2023.2298177. Epub 2024 Mar 25.NO ABSTRACTPMID:38527231 | DOI:10.1080/09273948.2023.2298177 (Source: Ocular Immunology and Inflammation)
Source: Ocular Immunology and Inflammation - March 25, 2024 Category: Allergy & Immunology Authors: Derrick P Smit Ilknur Tugal-Tutkun Jennifer E Thorne Source Type: research
